Why will Popularity of E-Clinical Solutions Surge Rapidly in Asia-Pacific (APAC) in Future?

The global e-clinical solutions market is predicted to rise from $2,997.0 million to more than $6,400.0 million from 2014 to 2020.

There has been a rapid rise in the popularity of e-clinical solutions over the last few years. This is attributed to the huge investments made by several clinical research, life sciences, biopharmaceutical, and pharmaceutical companies in research and development (R&D) activities over the last few years primarily for developing treatment programs for various diseases such as AIDS, cancer, and diabetes. For instance, the Australian medicine industry invests over $1.0 billion in pharmaceutical R&D activities every year. Besides this, the ballooning requirement of improved data standardization is also fueling the demand for e-clinical solutions across the world.

The other major factor contributing toward the surging popularity of e-clinical solutions is the increasing number of clinical trials being conducted all over the world, mainly because of the rising incidence of lifestyle-related disorders and chronic diseases and the surging geriatric population in several countries. Furthermore, many organizations and medical research firms are increasingly outsourcing clinical trials to other countries such as India, Poland, and China to curb the costs and increase the patient pool, which is, in turn, causing a sharp spike in the global demand for e-clinical solutions across the world.

Across the globe, the North American e-clinical solutions market exhibited the highest growth in the past and this trend will also continue in the upcoming years. This is credited to the increasing investments being made by the biotechnology and pharmaceutical companies in various research and development activities in the region. However, despite this factor, the usage of e-clinical solutions will grow at the fastest rate in the Asia-Pacific (APAC) region over the next few years, on account of the increasing outsourcing of clinical trials in various APAC countries such as India and China.

Therefore, it can be said with surety that the demand for e-clinical solutions will surge tremendously all over the world in the forthcoming years, primarily due to the increasing outsourcing of clinical trials and the increasing investments being made in R&D activities in the healthcare industry across the globe.

Author's Note

This study covers
• Major factors driving the market and their impact during the short, medium, and long terms
• Market restraints and their impact during the short, medium, and long terms
• Recent trends and evolving opportunities for the market participants
• Historical and the present size of the market segments and understand their comparative future potential
• Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings